1. Home
  2. RVMD vs BSAC Comparison

RVMD vs BSAC Comparison

Compare RVMD & BSAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RVMD
  • BSAC
  • Stock Information
  • Founded
  • RVMD 2014
  • BSAC 1977
  • Country
  • RVMD United States
  • BSAC Chile
  • Employees
  • RVMD N/A
  • BSAC N/A
  • Industry
  • RVMD Biotechnology: Biological Products (No Diagnostic Substances)
  • BSAC Commercial Banks
  • Sector
  • RVMD Health Care
  • BSAC Finance
  • Exchange
  • RVMD Nasdaq
  • BSAC Nasdaq
  • Market Cap
  • RVMD 8.7B
  • BSAC 9.1B
  • IPO Year
  • RVMD 2020
  • BSAC 1994
  • Fundamental
  • Price
  • RVMD $44.39
  • BSAC $18.90
  • Analyst Decision
  • RVMD Strong Buy
  • BSAC Hold
  • Analyst Count
  • RVMD 12
  • BSAC 3
  • Target Price
  • RVMD $64.67
  • BSAC $21.33
  • AVG Volume (30 Days)
  • RVMD 2.1M
  • BSAC 235.1K
  • Earning Date
  • RVMD 11-06-2024
  • BSAC 01-31-2025
  • Dividend Yield
  • RVMD N/A
  • BSAC 4.01%
  • EPS Growth
  • RVMD N/A
  • BSAC 79.37
  • EPS
  • RVMD N/A
  • BSAC 0.00
  • Revenue
  • RVMD $742,000.00
  • BSAC $2,155,933,253.00
  • Revenue This Year
  • RVMD N/A
  • BSAC N/A
  • Revenue Next Year
  • RVMD $1,855.42
  • BSAC $11.25
  • P/E Ratio
  • RVMD N/A
  • BSAC $10.58
  • Revenue Growth
  • RVMD N/A
  • BSAC 40.67
  • 52 Week Low
  • RVMD $25.93
  • BSAC $17.73
  • 52 Week High
  • RVMD $62.40
  • BSAC $21.43
  • Technical
  • Relative Strength Index (RSI)
  • RVMD 34.18
  • BSAC 44.20
  • Support Level
  • RVMD $42.53
  • BSAC $18.63
  • Resistance Level
  • RVMD $44.22
  • BSAC $19.08
  • Average True Range (ATR)
  • RVMD 1.59
  • BSAC 0.33
  • MACD
  • RVMD -0.27
  • BSAC -0.03
  • Stochastic Oscillator
  • RVMD 28.46
  • BSAC 28.57

About RVMD Revolution Medicines Inc.

Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio, and SOS1 and 4EBP1/mTORC1 programs.

About BSAC Banco Santander - Chile ADS

Founded in 1978, Banco Santander Chile is part of the Santander group and majority controlled by Santander Spain. Banco Santander is the largest bank in Chile by loans and the second largest by deposits. The bank generates most of its net interest income (roughly 65% of total revenue) from its mortgage, unsecured consumer credit lines, and commercial loans. Banco Santander's commercial loan business is more focused on small- to medium-sized companies, with firms generating more than CLP 10,000 million in revenue only making up around 5% of outstanding loans. Outside of lending, Banco Santander is the largest card issuer in the country with around 25% of the market and benefits from a long-term strategic partnership with the largest airline in the country LATAM Chile.

Share on Social Networks: